Systems Biology
|
OPPORTUNITY NUMBER |
OPPORTUNITY TITLE |
AGENCY NAME |
POSTED DATE |
CLOSE DATE |
|---|---|---|---|---|
| PAR-23-259 | Academic-Industrial Partnerships (AIP) to Translate and Validate In Vivo Imaging Systems (R01 Clinical Trial Optional) | HHS-NIH11 | 08/08/2023 | 01/07/2027 |
| PAR-23-264 | Assay development and screening for discovery of chemical probes, drugs or immunomodulators (R01 Clinical Trial Not Allowed) | HHS-NIH11 | 08/10/2023 | 09/07/2026 |
| PAR-23-245 | Personal Health Informatics for Delivering Actionable Insights to Individuals (R01 Clinical Trial Optional) | HHS-NIH11 | 08/09/2023 | 11/05/2026 |
| PAR-23-249 | Alcohol Treatment, Pharmacotherapy, and Recovery Research (R34 Clinical Trial required) | HHS-NIH11 | 08/09/2023 | 09/07/2026 |
| PAR-23-252 | Alcohol Health Services Research (R34 Clinical Trial Optional) | HHS-NIH11 | 08/09/2023 | 09/07/2026 |
| PAR-23-251 | Alcohol Health Services Research (R01 Clinical Trial Optional) | HHS-NIH11 | 08/09/2023 | 09/07/2026 |
| 2023-NIST-MSE-01 | Measurement Science and Engineering (MSE) Research Grant Programs | DOC-NIST | 04/14/2023 | 04/14/2025 |
| PAR-23-091 | Building in vivo Preclinical Assays of Circuit Engagement for Application in Therapeutic Development (R01 Clinical Trial Not Allowed) | HHS-NIH11 | 01/06/2023 | 09/07/2025 |
| PAR-22-140 | Systematic Testing of Radionuclides in Preclinical Experiments (STRIPE) (R21 Clinical Trial Not Allowed) | HHS-NIH11 | 03/18/2022 | 05/07/2025 |
| PAR-22-139 | Systematic Testing of Radionuclides in Preclinical Experiments (STRIPE) (R01 Clinical Trial Not Allowed) | HHS-NIH11 | 03/18/2022 | 05/07/2025 |
| PAR-22-099 | Cancer Tissue Engineering Collaborative: Enabling Biomimetic Tissue-Engineered Technologies for Cancer Research (R01 Clinical Trial Optional) | HHS-NIH11 | 01/21/2022 | 05/07/2025 |
| PAR-22-060 | Research Enhancement Award Program (REAP) for Health Professional Schools and Graduate Schools (R15 Clinical Trial Not Allowed) | HHS-NIH11 | 01/10/2022 | 01/07/2025 |
| RFA-NS-22-034 | HEAL Initiative: Discovery and Validation of Novel Targets for Safe and Effective Pain Treatment (R01 Clinical Trial Not Allowed) | HHS-NIH11 | 01/07/2022 | 12/06/2024 |
| PAR-22-031 | Drug Discovery For Nervous System Disorders (R01 Clinical Trials Not Allowed) | HHS-NIH11 | 11/29/2021 | 01/07/2025 |
| PAR-22-032 | Drug Discovery For Nervous System Disorders (R21 Clinical Trials Not Allowed) | HHS-NIH11 | 11/17/2021 | 01/07/2025 |
|
PAR-22-070 |
NEI Regenerative Medicine Clinical Trial Planning Grant (R34 - Clinical Trials Not Allowed) | HHS-NIH11 | 11/16/2021 | 01/07/2025 |
| PA-21-266 | Patient Safety Learning Laboratories: Advancing Patient Safety through Design, Systems Engineering, and Health Services Research (R18 Clinical Trial Optional) | HHS-AHRQ | 06/25/2021 | 05/26/2025 |
| PAR-21-229 | Screening and Functional Validation of Human Birth Defects Genomic Variants (R01 Clinical Trial Not Allowed) | HHS-NIH11 | 05/05/2021 | 05/07/2025 |